首页> 外文期刊>RSC Advances >Stable micelles formed through a stereocomplex of amphiphilic copolymers zwitterionic-(PLLA)(2) and MPEG-(PDLA)(2) for controlled drug delivery
【24h】

Stable micelles formed through a stereocomplex of amphiphilic copolymers zwitterionic-(PLLA)(2) and MPEG-(PDLA)(2) for controlled drug delivery

机译:通过两亲性共聚物两性离子-(PLLA)(2)和MPEG-(PDLA)(2)的立体配合物形成的稳定胶束

获取原文
获取原文并翻译 | 示例
           

摘要

Y-Shaped amphiphilic copolymers (zwitterionic-(PLLA(2.5K))(2) and MPEG-(PDLA(2.5K))(2)) were simply synthesized through click reaction of alkyne-(PLA(2.5K))(2) and zwittterionic-N-3 or MPEG-N-3. Gel permeation chromatography (GPC) and H-1 nuclear magnetic resonance (H-1 NMR) were employed to characterize the composition and structure of these copolymers. The stereocomplexes were prepared from pairs zwitterionic-(PLLA(2.5K))(2)/MPEG-(PDLA(2.5K))(2) (molar ratio = 1 : 1), and confirmed by differential scanning calorimeter (DSC). Furthermore the aggregation behaviors for these synthesized polymers and their stereocomplexes had been proved by fluorescence spectroscopy (PL), transmission electron microscopy (TEM), dynamic light scattering (DLS) and static light scattering (SLS), and zeta potential. Their critical micelle concentration (CMC) obtained by PL was 0.0213 mg mL(-1) for zwitterionic-(PLLA(2.5K))(2)/MPEG(1.9K)-(PDLA(2.5K))(2) and 0.1265 mg mL(-1) for zwitterionic-(PLLA(2.5K))(2)/MPEG(5K-)(PDLA(2.5K))(2). The stereocomplexes could self-assemble into spherical micelles with diameters of 76 nm (zwitterionic-(PLLA(2.5K))(2)/MPEG(1.9K)-(PDLA(2.5K))(2)) and 89 nm (zwitterionic-(PLLA(2.5K))(2)/MPEG(5K)-(PDLA(2.5K))(2)) respectively. The biocompatibility of these copolymers and their stereocomplexes was evaluated with relatively low cytotoxicity. The DOX-loaded micelles of the stereocomplexes had a higher drug loading content and encapsulation efficiency, and could release DOX in a controlled manner. Therefore, the new stereocomplex zwitterionic-(PLLA)(2)/MPEG-(PDLA)(2) has great potential as a hydrophobic drug nanocarrier.
机译:Y型两亲共聚物(两性离子-(PLLA(2.5K))(2)和MPEG-(PDLA(2.5K))(2))是通过炔-(PLA(2.5K))(2的点击反应)简单合成的)和zwittterionic-N-3或MPEG-N-3。凝胶渗透色谱法(GPC)和H-1核磁共振(H-1 NMR)用于表征这些共聚物的组成和结构。由两性离子-(PLLA(2.5K))(2)/ MPEG-(PDLA(2.5K))(2)(摩尔比= 1:1)对制备立体复合物,并通过差示扫描量热仪(DSC)进行确认。此外,这些合成的聚合物及其立体配合物的聚集行为已通过荧光光谱(PL),透射电子显微镜(TEM),动态光散射(DLS)和静态光散射(SLS)以及zeta电位进行了证明。通过PL获得的两性离子-(PLLA(2.5K))(2)/ MPEG(1.9K)-(PDLA(2.5K))(2)的临界胶束浓度(CMC)为0.0213 mg mL(-1)和0.1265两性离子-(PLLA(2.5K))(2)/ MPEG(5K-)(PDLA(2.5K))(2)的mg mL(-1)。立体复合物可以自组装成直径为76 nm的球形胶束(两性离子-(PLLA(2.5K))(2)/ MPEG(1.9K)-(PDLA(2.5K))(2))和89 nm(两性离子-(PLLA(2.5K))(2)/ MPEG(5K)-(PDLA(2.5K))(2))。用相对较低的细胞毒性评估了这些共聚物及其立体复合物的生物相容性。立体复合物的DOX负载胶束具有较高的载药量和包封效率,并且可以受控方式释放DOX。因此,新型立体复合物两性离子-(PLLA)(2)/ MPEG-(PDLA)(2)具有作为疏水性药物纳米载体的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号